- Home
- Member Resources
- Articles
- Precision Medicine
-
CAP member Dr. Joseph Willis writes how the advent of new molecularly targeted treatment strategies for patients with advanced colorectal cancer places anatomic and molecular pathologists as key players in the delivery of care for this large patient population.
-
Genomic profiling helps to accurately classify disease, provide prognostic risk classification, and drive therapy management for patients with chronic myeloid stem cell disorders and acute leukemia.
-
Exciting clinical microbiology advancements have been made in the last several years, especially regarding the rapid molecular identification of pathogenic organisms and workflow automation.
-
Molecular diagnostics have broadened our ability to diagnose and identify prognostic markers in cases of myeloproliferative neoplasms. However, challenges remain, specifically with so-called “triple-negative” MPNs.
-
This article summarizes the utility of next-generation sequencing (NGS) for human leukocyte antigen genotyping, highlighting the advantages of this approach over other molecular methods for typing HLA alleles.
-
This article by CAP member Dr. Jordan Laser focuses on the role of the pathologist in utilization management.
-
This article focuses on germline genetic variants that can be used to identify the most appropriate medication and dose for a patient.